Qsymia Another New But Old Kid on the Block? Health Evolved FDA approves new version of diabetes drug Mounjaro for weight loss Compounded Tirzepatide GLP 1 GIP Care Provider Guided Through nky In a patient on GLP1 receptor agonist therapy presenting with a severalhour headache, mild dehydration, and serum sodium of 128 mmol L, could the headache and hyponatremia be caused by the GLP1 medication? Sleep apnea: Zepbound, Mounjaro improves symptoms in clinical trial